SEC Company Response from Zai Lab Ltd (ZLAB) (CIK 0001704292) (ZLAB) — Sep 15, 2017
Zai Lab Ltd (ZLAB) (CIK 0001704292)
Date: Sept. 15, 2017 · CIK: 0001704292 · Accession: 0001193125-17-286070
AI Filing Summary & Sentiment
File numbers found in text: 001-38205, 333-219980
Letter
J.P. Morgan Securities LLC
383 Madison Avenue
New York, New York 10179
Citigroup Global Markets Inc.
390 Greenwich Street
New York, New York 10013
Leerink Partners LLC
One Federal Street, 37th Floor
Boston, MA 02110
September 15, 2017
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-7010
Attn: Suzanne Hayes / Vanessa Robertson
James Rosenberg / Chris Edwards
Re: Zai Lab Limited
Registration Statement on Form F-1, as amended (File No. 333-219980)
Registration Statement on Form 8-A (File No. 001-38205)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representative of the several underwriters, hereby join in the request of Zai Lab Limited (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Daylight Time, on September 19, 2017 or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Ropes & Gray LLP, may orally request by telephone call that such Registration Statement be declared effective.
Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated September 1, 2017:
(i) Dates of distribution: September 1, 2017 through the date hereof
(ii) Number of prospective underwriters to which the preliminary prospectus was furnished: 3
(iii) Number of prospectuses furnished to investors: approximately 3,000
(iv) Number of prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: approximately 50
We, the undersigned, as representative of the several underwriters, have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
J.P. MORGAN SECURITIES LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 Citigroup Global Markets Inc. 390 Greenwich Street New York, New York 10013 Leerink Partners LLC One Federal Street, 37th Floor Boston, MA 02110 September 15, 2017 Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-7010 Attn: Suzanne Hayes / Vanessa Robertson James Rosenberg / Chris Edwards Re: Zai Lab Limited Registration Statement on Form F-1, as amended (File No. 333-219980) Registration Statement on Form 8-A (File No. 001-38205) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representative of the several underwriters, hereby join in the request of Zai Lab Limited (the “Company”) for acceleration of the effective date of the above-named Registration Statement so that it becomes effective at 4:00 PM, Eastern Daylight Time, on September 19, 2017 or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Ropes & Gray LLP, may orally request by telephone call that such Registration Statement be declared effective. Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus dated September 1, 2017: (i) Dates of distribution: September 1, 2017 through the date hereof (ii) Number of prospective underwriters to which the preliminary prospectus was furnished: 3 (iii) Number of prospectuses furnished to investors: approximately 3,000 (iv) Number of prospectuses distributed to others, including the Company, the Company’s counsel, independent accountants, and underwriters’ counsel: approximately 50 We, the undersigned, as representative of the several underwriters, have complied and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, J.P. MORGAN SECURITIES LLC CITIGROUP GLOBAL MARKETS INC. LEERINK PARTNERS LLC By: J.P. MORGAN SECURITIES LLC By: /s/ David Ke Name: David Ke Title: Vice President By: CITIGROUP GLOBAL MARKETS INC. By: /s/ Russell Chong Name: Russell Chong Title: Managing Director By: LEERINK PARTNERS LLC By: /s/ John I. Fitzgerald Name: John Fitzgerald Title: Managing Director